A Safety and Efficacy of DRM02 in Subjects With Atopic Dermatitis

NCT01993420 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
21
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Dermira, Inc.